• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Long-acting coronary vasodilatory action of the molsidomine metabolite Sin 1: a quantitative angiographic study.

作者信息

Serruys P W, Deckers J W, Luijten H E, Reiber J H, Tijssen J G, Chadha D, Hugenholtz P G

出版信息

Eur Heart J. 1987 Mar;8(3):263-70. doi: 10.1093/oxfordjournals.eurheartj.a062268.

DOI:10.1093/oxfordjournals.eurheartj.a062268
PMID:3582385
Abstract

The vasodilatory action of molsidomine was studied by intracoronary injection of its active metabolite, Sin 1. In 10 patients repeat coronary angiography in multiple projections was performed before and 2 minutes after administration of 1 mg of Sin 1, and before and after a second injection 60 minutes later. Contours of obstructed and non-obstructed segments of the left coronary artery were quantitatively analysed with a computer-based angiography analysis system. Immediately after its administration, Sin 1 increased the mean diameters of 44 normal coronary segments by 12% (P less than 0.001). Significant vasodilation (8%) was still observed after 60 minutes. At that time, repeated administration of Sin 1 increased the vasodilation by an additional 14% with respect to the control situation. An increase in obstruction diameter was observed in 6 out of 8 obstructed segments. Mean increase in the minimal obstruction diameter was still 10% after 60 minutes.

摘要

相似文献

1
Long-acting coronary vasodilatory action of the molsidomine metabolite Sin 1: a quantitative angiographic study.
Eur Heart J. 1987 Mar;8(3):263-70. doi: 10.1093/oxfordjournals.eurheartj.a062268.
2
[Diameter changes of epicardial coronary arteries and coronary stenoses after intracoronary application of SIN 1, a molsidomine metabolite].[应用硝普钠代谢物SIN 1冠脉内给药后心外膜冠状动脉直径变化及冠状动脉狭窄情况]
Z Kardiol. 1983 Jul;72(7):404-9.
3
The new long-acting coronary artery dilator molsidomine and its metabolite SIN-1.
Am Heart J. 1985 Mar;109(3 Pt 2):700-3. doi: 10.1016/0002-8703(85)90686-6.
4
Active and passive changes in coronary diameter after vasodilation with SIN-1, the active metabolite of molsidomine.用吗多明的活性代谢物SIN-1进行血管舒张后冠状动脉直径的主动和被动变化。
Am Heart J. 1985 Mar;109(3 Pt 2):694-9. doi: 10.1016/0002-8703(85)90685-4.
5
Nitroglycerin-resistant coronary spasm treated with intracoronary linsidomine chlorhydrate (SIN-1).用冠状动脉内注射盐酸林西多明(SIN-1)治疗对硝酸甘油耐药的冠状动脉痉挛。
Eur Heart J. 1990 May;11(5):472-5. doi: 10.1093/oxfordjournals.eurheartj.a059731.
6
Intracoronary linsidomine abolishes acetylcholine-induced vasoconstriction of epicardial coronary arteries.冠状动脉内应用林西多明可消除乙酰胆碱诱导的心外膜冠状动脉血管收缩。
J Cardiovasc Pharmacol. 1993 Sep;22(3):462-7. doi: 10.1097/00005344-199309000-00018.
7
[Coronary dilatation after intracoronary administration of SIN-1 and intravenous molsidomine administration].[冠状动脉内注射SIN-1及静脉注射吗多明后的冠状动脉扩张]
Med Klin (Munich). 1994 Jul;89 Suppl 2:34-7.
8
[Anti-ischemic effects of SIN-1, a molsidomine metabolite, during coronary angioplasty and antiplatelet effects in humans].
Presse Med. 1988 May 25;17(20):1033-6.
9
[Effects of intracoronary injection of SIN-1 on vasoconstriction of epicardial arteries induced by acetylcholine].[冠状动脉内注射SIN-1对乙酰胆碱诱导的心外膜动脉血管收缩的影响]
Arch Mal Coeur Vaiss. 1993 Jun;86(6):881-7.
10
Coronary vasodilatory action after nicorandil: a quantitative angiographic study.
Am J Cardiol. 1989 Jun 20;63(21):80J-85J. doi: 10.1016/0002-9149(89)90211-7.

引用本文的文献

1
Nitric Oxide-Based Treatment of Poor-Grade Patients After Severe Aneurysmal Subarachnoid Hemorrhage.基于一氧化氮的治疗策略用于改善重症动脉瘤性蛛网膜下腔出血患者的预后
Neurocrit Care. 2020 Jun;32(3):742-754. doi: 10.1007/s12028-019-00809-1.
2
[State of diagnostics and therapy of inflammatory cardiomyopathie].[炎症性心肌病的诊断与治疗现状]
Internist (Berl). 2008 Jan;49(1):7-16. doi: 10.1007/s00108-007-1966-y.
3
Immunosuppressive therapy in acute myocarditis: an 18 year systematic review.急性心肌炎的免疫抑制治疗:一项18年的系统评价
Arch Dis Child. 2004 Jun;89(6):580-4. doi: 10.1136/adc.2003.034686.
4
The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review.急性心肌炎在自发改善与进展为扩张型心肌病之间的转归:综述
Heart. 2001 May;85(5):499-504. doi: 10.1136/heart.85.5.499.
5
How to standardize vasomotor tone in serial studies based on quantitation of coronary dimensions?
Int J Card Imaging. 1998 Dec;14(6):357-72. doi: 10.1023/a:1006076409185.
6
Nonresponsiveness to antianginal therapy--a frequent problem?
Cardiovasc Drugs Ther. 1988 May;2(1):71-7. doi: 10.1007/BF00054255.